Gaedigk A - Search Results

1

CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements.

Claudio-Campos KI, González-Santiago P, Renta JY, Rodríguez J, Carrasquillo K, Gaedigk A, Roche A, Ducongé J. Claudio-Campos KI, et al. Among authors: gaedigk a. Pharmacogenomics. 2019 Jan;20(1):3-8. doi: 10.2217/pgs-2018-0143. Epub 2018 Dec 6. Pharmacogenomics. 2019. PMID: 30518301 Free PMC article.

2

CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR.

Gaedigk A, Twist GP, Leeder JS. Gaedigk A, et al. Pharmacogenomics. 2012 Jan;13(1):91-111. doi: 10.2217/pgs.11.135. Epub 2011 Nov 23. Pharmacogenomics. 2012. PMID: 22111604

3

High-resolution melt analysis to detect sequence variations in highly homologous gene regions: application to CYP2B6.

Twist GP, Gaedigk R, Leeder JS, Gaedigk A. Twist GP, et al. Among authors: gaedigk a, gaedigk r. Pharmacogenomics. 2013 Jun;14(8):913-22. doi: 10.2217/pgs.13.66. Pharmacogenomics. 2013. PMID: 23746185 Free PMC article.

4

CYP2D6 and pharmacogenomics: where does future research need to focus? Part 1: technical aspects.

Gaedigk A, Leeder JS. Gaedigk A, et al. Pharmacogenomics. 2014 Mar;15(4):407-10. doi: 10.2217/pgs.14.28. Pharmacogenomics. 2014. PMID: 24624906 No abstract available.

5

CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.

Leeder JS, Gaedigk A. Leeder JS, et al. Among authors: gaedigk a. Pharmacogenomics. 2014 Jun;15(8):1055-8. doi: 10.2217/pgs.14.27. Pharmacogenomics. 2014. PMID: 25084197 No abstract available.

6

Resolution of a clinical AmpliChip CYP450 Test™ no call: discovery and characterization of novel CYP2D6*1 haplotypes.

Gaedigk A, Garcia-Ribera C, Jeong HE, Shin JG, Hernandez-Sanchez J. Gaedigk A, et al. Pharmacogenomics. 2014 Jun;15(9):1175-84. doi: 10.2217/pgs.14.94. Pharmacogenomics. 2014. PMID: 25141893

7

CYP450 genotype and pharmacogenetic association studies: a critical appraisal.

Shah RR, Gaedigk A, LLerena A, Eichelbaum M, Stingl J, Smith RL. Shah RR, et al. Among authors: gaedigk a. Pharmacogenomics. 2016 Feb;17(3):259-75. doi: 10.2217/pgs.15.172. Epub 2016 Jan 18. Pharmacogenomics. 2016. PMID: 26780308

8

Pharmacogenetics to prevent maniac affective switching with treatment for bipolar disorder: CYP2D6.

Sánchez-Martín A, Sánchez-Iglesias S, García-Berrocal B, Lorenzo C, Gaedigk A, Isidoro-García M. Sánchez-Martín A, et al. Among authors: gaedigk a. Pharmacogenomics. 2016 Aug;17(12):1291-3. doi: 10.2217/pgs-2016-0105. Epub 2016 Jul 29. Pharmacogenomics. 2016. PMID: 27469479 Review. No abstract available.

9

In vivo characterization of CYP2D6*12, *29 and *84 using dextromethorphan as a probe drug: a case report.

Gaedigk A, Twist GP, Farrow EG, Lowry JA, Soden SE, Miller NA. Gaedigk A, et al. Pharmacogenomics. 2017 Apr;18(5):427-431. doi: 10.2217/pgs-2016-0192. Epub 2017 Mar 14. Pharmacogenomics. 2017. PMID: 28290770

10

Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study.

Chaudhry M, Alessandrini M, Rademan J, Dodgen TM, Steffens FE, van Zyl DG, Gaedigk A, Pepper MS. Chaudhry M, et al. Among authors: gaedigk a. Pharmacogenomics. 2017 Apr;18(5):433-443. doi: 10.2217/pgs-2016-0185. Epub 2017 Mar 28. Pharmacogenomics. 2017. PMID: 28350251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters